Conference icon

Conference

Intravenous immune globulin in chronic lymphocytic leukaemia.

Abstract:

The most common complication of chronic lymphocytic leukaemia (CLL) is infection, which occurs mainly in advanced stages of disease or in those patients with hypogammaglobulinaemia. Intravenous immune globulin (IVIG) has been shown to be a useful prophylactic therapy against infections in such patients. A randomized, double-blind study on 36 patients receiving either 500 mg/kg or 250 mg/kg IVIG every 4 weeks was undertaken to determine the dose regimen required. There was no significant diffe...

Expand abstract
Publication status:
Published

Actions


Authors


More by this author
Institution:
University of Oxford
Department:
Oxford, MSD, Clinical Medicine, Experimental Medicine Division,
Role:
Author
Expand authors...
Volume:
97 Suppl 1
Pages:
17-20
Publication date:
1994-07-05
EISSN:
1365-2249
ISSN:
0009-9104
URN:
uuid:41cebeee-daf5-4943-965f-f27bd9c74a63
Source identifiers:
66982
Local pid:
pubs:66982

Terms of use


Metrics


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP